The neuromelanin of human substantia nigra: physiological and pathogenic aspects.
about
Dopamine covalently modifies and functionally inactivates parkinEctopic expression of tyrosine hydroxylase in the pigmented epithelium rescues the retinal abnormalities and visual function common in albinos in the absence of melaninMALDI imaging mass spectrometry and analysis of endogenous peptides.The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface.Tracemetals, neuromelanin and neurodegeneration: An interesting area for researchChemistry of mixed melanogenesis--pivotal roles of dopaquinone.Parkinson's disease, lights and melanocytes: looking beyond the retina.Role of semiconductivity and ion transport in the electrical conduction of melanin.Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.The ubiquitin E3 ligase parkin regulates the proapoptotic function of BaxHuman neuromelanin: an endogenous microglial activator for dopaminergic neuron deathNeuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic interventionNew melanic pigments in the human brain that accumulate in aging and block environmental toxic metals.Glutathione metabolism and Parkinson's disease.The expanding role and presence of neuromelanins in the human brain - why gray matter is gray.What are melanocytes really doing all day long...?Iron-dependent functions of mitochondria--relation to neurodegeneration.The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's diseaseBlood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.Neuromelanin activates proinflammatory microglia through a caspase-8-dependent mechanism.5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease.Testicular melanization has evolved in birds with high mtDNA mutation rates.Theoretical models of eumelanin protomolecules and their optical properties.DMT1 as a candidate for non-transferrin-bound iron uptake in the peripheral nervous system.Occupational Metal Exposure and Parkinsonism.A reappraisal of Fe(III) adsorption by melanin.Brain size and the expression of pheomelanin-based colour in birds.The structural impact of water sorption on device-quality melanin thin films.Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.Structural model of eumelanin.The photoreactive free radical in eumelanin.
P2860
Q24338423-1B720617-3CFD-4578-968A-00294FB93CC0Q28510352-59D1BAD6-0B65-49B6-A3A3-BE5EA63C04A3Q31134599-93232B5A-5DCB-4019-9208-91CF16993BC7Q33258374-B6617210-5DBA-4BC7-859C-357F3B5C27DBQ33984927-904469C7-54E0-4EA4-99BB-54D83AFC7FDCQ34011322-3C86AF96-85BA-4001-9175-6DDD3A984A53Q34400617-C236E203-FEAB-4773-AA77-1E8C34577BEAQ34638488-992A5914-A12B-4A57-B8EF-BCC5B9D7FF29Q35834043-E62D6C32-58BC-45DD-848F-28106738B528Q35925042-5C75812E-0EDA-462E-BFC4-B3567015B172Q36766407-0A038DB7-627F-428F-A262-B1261731EFF9Q36919403-3E4238E4-E7E5-495B-AB74-2E1BB735D2B0Q36971051-A95EF96C-3160-4D5C-B2E4-31EDE6FB8AE4Q37078480-DCDADFCF-2853-46FF-923A-B35245F76350Q37468687-D03C6914-BBBF-48D7-92D8-8130C5FD3397Q37472801-F97BA4A9-B4D5-4ED8-96A3-68F6342AC947Q37821334-256F39A7-CD45-4083-837C-E98480FD945EQ37845675-2BF3A6EE-AAD8-4196-B698-4A931E597C96Q37881948-25912742-DF7C-4B82-A16F-70841CB1C3BAQ38920210-3FA7BA3F-4AD2-430E-8BF5-76444D9D216FQ39055876-2D14E97B-6A1E-4AE3-AD4B-CEF99E25C1B4Q39784789-9AE39753-C50F-4608-829D-A7E1BF1EFF14Q41852322-06CE677B-5E1F-4CCB-921A-83A3ADEA4872Q44832121-71D0504D-7200-4E49-98AC-4A8D11910FFCQ46309593-207DFBB0-1CB9-49D5-8E4B-D381BBD14C5BQ46891982-8D38E29F-4B37-4B45-A0E2-3F94E4DF6E00Q47390380-FFAE7178-8E42-4C6F-9E7E-89855AE8C545Q50875451-18D56D9C-5969-493B-870B-7BB9C2B354A1Q51066366-EF98CC4A-3083-4226-904F-F5DF7C629D23Q51095666-48F0E5D1-F7C7-4D17-90A9-4E2687A5B26FQ52620132-DC6F126D-9F53-45F8-8F70-E43C26F794DA
P2860
The neuromelanin of human substantia nigra: physiological and pathogenic aspects.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The neuromelanin of human substantia nigra: physiological and pathogenic aspects.
@ast
The neuromelanin of human substantia nigra: physiological and pathogenic aspects.
@en
type
label
The neuromelanin of human substantia nigra: physiological and pathogenic aspects.
@ast
The neuromelanin of human substantia nigra: physiological and pathogenic aspects.
@en
prefLabel
The neuromelanin of human substantia nigra: physiological and pathogenic aspects.
@ast
The neuromelanin of human substantia nigra: physiological and pathogenic aspects.
@en
P2093
P2860
P50
P1476
The neuromelanin of human substantia nigra: physiological and pathogenic aspects.
@en
P2093
Giuseppe Giaveri
Henrik Wilms
Luigi Zecca
Marco Toscani
Mario Gallorini
Ralph Lucius
P2860
P304
P356
10.1111/J.1600-0749.2004.00201.X
P577
2004-12-01T00:00:00Z